Eric Coldwell
Stock Analyst at Robert W. Baird
Total Price Targets
46
Stocks Covered
15
Sectors
Consumer Cyclical, Healthcare, Industrials
Most Recent
Feb 19, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Eric Coldwell
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CRL | Charles River Laboratories International, Inc. | $193.00 | $165.56 | +16.6% | 3 | Feb 19, 2026 |
| MCK | McKesson Corporation | $968.00 | $817.15 | +18.5% | 8 | Jan 14, 2026 |
| CAH | Cardinal Health, Inc. | $250.00 | $195.04 | +28.2% | 6 | Jan 14, 2026 |
| COR | Cencora, Inc. | $415.00 | $305.35 | +35.9% | 1 | Jan 13, 2026 |
| MDLN | Medline Inc. | $48.00 | $44.52 | +7.8% | 1 | Jan 12, 2026 |
| ACH | Accendra Health, Inc. | $5.00 | $3.73 | +34.0% | 8 | Jan 6, 2026 |
| IQV | IQVIA Holdings Inc. | $258.00 | $156.85 | +64.5% | 3 | Oct 29, 2025 |
| FTRE | Fortrea Holdings Inc. | $14.00 | $12.02 | +16.5% | 2 | Sep 3, 2025 |
| DGX | Quest Diagnostics Incorporated | $189.00 | $192.76 | -2.0% | 3 | Jan 31, 2025 |
| AHCO | AdaptHealth Corp. | $14.00 | $13.21 | +6.0% | 2 | Nov 6, 2024 |
| MEDP | Medpace Holdings, Inc. | $349.00 | $417.74 | -16.5% | 3 | Oct 23, 2024 |
| TFII | TFI International Inc. | $349.00 | $142.39 | +145.1% | 1 | Oct 23, 2024 |
| ICLR | ICON Public Limited Company | $340.00 | $112.39 | +202.5% | 3 | Sep 20, 2024 |
| LH | Labcorp Holdings Inc. | $277.00 | $256.56 | +8.0% | 1 | Aug 2, 2024 |
| DIN | Dine Brands Global, Inc. | $55.00 | $27.06 | +103.3% | 1 | Oct 17, 2023 |
Recent Activity
- Feb 19, 2026— Set$193.00price target onCRL(Charles River Laboratories International, Inc.)
- Jan 14, 2026— Set$968.00price target onMCK(McKesson Corporation)
- Jan 14, 2026— Set$250.00price target onCAH(Cardinal Health, Inc.)
- Jan 13, 2026— Set$415.00price target onCOR(Cencora, Inc.)
- Jan 12, 2026— Set$48.00price target onMDLN(Medline Inc.)
- Jan 9, 2026— Set$224.00price target onCRL(Charles River Laboratories International, Inc.)
- Jan 6, 2026— Set$5.00price target onACH(Accendra Health, Inc.)
- Oct 29, 2025— Set$258.00price target onIQV(IQVIA Holdings Inc.)
- Sep 3, 2025— Set$14.00price target onFTRE(Fortrea Holdings Inc.)
- Aug 8, 2025— Set$10.00price target onACH(Accendra Health, Inc.)
- Jan 31, 2025— Set$189.00price target onDGX(Quest Diagnostics Incorporated)
- Nov 7, 2024— Set$688.00price target onMCK(McKesson Corporation)
- Nov 6, 2024— Set$14.00price target onAHCO(AdaptHealth Corp.)
- Nov 5, 2024— Set$14.00price target onACH(Accendra Health, Inc.)
- Oct 23, 2024— Set$349.00price target onMEDP(Medpace Holdings, Inc.)
- Oct 23, 2024— Set$349.00price target onTFII(TFI International Inc.)
- Oct 23, 2024— Set$182.00price target onDGX(Quest Diagnostics Incorporated)
- Sep 24, 2024— Set$531.00price target onMCK(McKesson Corporation)
- Sep 23, 2024— Set$19.00price target onACH(Accendra Health, Inc.)
- Sep 23, 2024— Set$16.00price target onAHCO(AdaptHealth Corp.)
Frequently Asked Questions
Who is Eric Coldwell?
Eric Coldwell is a stock analyst at Robert W. Baird covering 15 stocks primarily in Consumer Cyclical, Healthcare, Industrials. They have issued 46 price targets since Feb 2, 2022.
What stocks does Eric Coldwell cover?
Eric Coldwell currently covers 15 stocks, including MCK, ACH, CAH, CRL, IQV.
What is Eric Coldwell's latest price target?
Eric Coldwell's most recent price target was $193.00 on CRL (Charles River Laboratories International, Inc.), set on Feb 19, 2026.
What is Eric Coldwell's highest price target?
Eric Coldwell's highest issued price target is $968.00 on MCK, set on Jan 14, 2026.
More Analysts at Robert W. Baird
Coverage based on publicly published price targets. Not investment advice.